NK cell + OV therapy(Virocure Inc)

N/A

Report date: 2025/12/23 17:47:52

Base Information

Drug NameNK cell + OV therapy(Virocure Inc)

Drug Alias NameNK cell + Oncolytic virus therapy(Virocure Inc)NK cell/OV therapy(Virocure Inc)NK cell/Oncolytic virus therapy(Virocure Inc)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyBiologics > Oncolytic virus

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVirocure Inc

China Registration ClassN/A

Develop Information

Active CompaniesVirocure Inc

Inactive CompaniesN/A

Active IndicationsUrinary Bladder Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A